Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 10 results.
User Information
Export Records
  1. 1.   Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model
  2. Zhu, Guangwei; Zhao, Ming; Han, Qinghong; Tan, Yuying; Sun, Y U; Bouvet, Michael; Clary, Bryan; Singh,Shree Ram; Ye, Jianxin; Hoffman, Robert M
  3. Anticancer research. 2019, Dec; 39(12): 6463-6470.
  1. 2.   Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Zhu, Guangwei; Zhao, Ming; Han, Qinghong; Tan, Yuying; Sun, Y U; Bouvet, Michael; Singh,Shree Ram; Ye, Jianxin; Hoffman, Robert M
  3. Anticancer research. 2019, Nov; 39(11): 5999-6005.
  1. 3.   Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Oshiro, Hiromichi; Tome, Yasunori; Kiyuna, Tasuku; Yoon, Sang Nam; Lwin, Thinzar M; Han, Qinghong; Tan, Yuying; Miyake, Kentaro; Higuchi, Takashi; Sugisawa, Norihiko; Katsuya, Yuki; Park, Jun Ho; Zang, Zhiying; Razmjooei, Sahar; Bouvet, Michael; Clary, Bryan; Singh,Shree Ram; Kanaya, Fuminori; Nishida, Kotaro; Hoffman, Robert M
  3. Anticancer research. 2019, Sep; 39(9): 4667-4671.
  1. 4.   Non-coding rRNA-mediated preferential killing in cancer cells is enhanced by suppression of autophagy in non-transformed counterpart
  2. Hwang, C. J.; Fields, J. R.; Shiao, Y. H.
  3. Cell Death & Disease. 2011, Dec; 2
  1. 5.   2 '-deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: A novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase
  2. Byun, H. M.; Choi, S. H.; Laird, P. W.; Trinh, B.; Siddiqui, M. A.; Marquez, V. E.; Yang, A. S.
  3. Cancer Letters. 2008 266(2): 238-248.
  1. 6.   Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas
  2. Chen, M.; Rahman, L.; Voeller, D.; Kastanos, E.; Yang, S. X.; Feigenbaum, L.; Allegra, C.; Kaye, F. J.; Steeg, P.; Zajac-Kaye, M.
  3. Oncogene. 2007, Jul; 26(33): 4817-4824.
  1. 7.   Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy
  2. Shebzukhov, Y. V.; Koroleva, E. P.; Khlgatian, S. V.; Lagarkova, M. A.; Meshcheryakov, A. A.; Lichinitser, M. R.; Karbach, J.; Jager, E.; Kuprash, D. V.; Nedospasov, S. A.
  3. Immunology Letters. 2005, AUG 15; 100(1): 88-93.
  1. 8.   Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O-6-methylguanine-DNA methyltransferase with O-6-benzylguanine or O-6-benzyl-2 '- deoxyguanosine
  2. Kokkinakis, D. M.; Ahmed, M. M.; Chendil, D.; Moschel, R. C.; Pegg, A. E.
  3. Clinical Cancer Research. 2003 9(10, Part 1): 3801-3807.
  1. 9.   The identification of thymidylate synthase peptide domains located in the interface region that bind thymidylate synthase mRNA
  2. Voeller, D. M.; Zajac-Kaye, M.; Fisher, R. J.; Allegra, C. J.
  3. Biochemical and Biophysical Research Communications. 2002 297(1): 24-31.
  1. 10.   Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the national cancer institute's anticancer drug screen
  2. Grem, J. L.; Danenberg, K. D.; Behan, K.; Parr, A.; Young, L.; Danenberg, P. V.; Nguyen, D.; Drake, J.; Monks, A.; Allegra, C. J.
  3. Clinical Cancer Research. 2001 7(4): 999-1009.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel